Clonidine‐induced nitric oxide‐dependent vasorelaxation mediated by endothelial α2‐adrenoceptor activation

dc.contributor.authorFigueroa, Xavier
dc.contributor.authorBoric P., Mauricio
dc.contributor.authorHuidobro-Toro, Juan Pablo
dc.date.accessioned2017-04-25T19:24:42Z
dc.date.available2017-04-25T19:24:42Z
dc.date.issued2001
dc.identifier.doi10.1038/sj.bjp.0704320
dc.identifier.issn0007-1188
dc.identifier.urihttps://doi.org/10.1038/sj.bjp.0704320
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/20438
dc.language.isoen
dc.nota.accesoContenido completo
dc.relation.isformatofBritish Journal of Pharmacology Vol. 134, no. 5 (2001), p. [957]-968
dc.revistaBritish Journal of Pharmacologyes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherVasodilataciónes_ES
dc.subject.otherArteriaes_ES
dc.subject.otherReceptores adrenérgicos alfa-2es_ES
dc.subject.otherEndotelioes_ES
dc.titleClonidine‐induced nitric oxide‐dependent vasorelaxation mediated by endothelial α2‐adrenoceptor activationes_ES
dc.typeartículo
sipa.codpersvinculados1437
sipa.codpersvinculados56355
sipa.codpersvinculados98862
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Clonidine‐induced nitric oxide‐dependent vasorelaxation mediated by endothelial α2‐adrenoceptor activation.pdf
Size:
314.02 KB
Format:
Adobe Portable Document Format
Description: